← All Topics / evidence-ade-crossref

Cross-reference: "pentosan" — FDA ADE ↔ evidence

evidence_ade_crossref_pentosan

evidence-ade-crossref 300 tok en 2026-08-11

Cross-reference: "pentosan" — FDA ADE reports ↔ evidence literature

A structural index linking the evidence layer (Europe PMC literature topics) and the FDA adverse-event (ADE) layer (openFDA animal-drug reports) by shared mention of the term "pentosan". No new data was fetched; this topic is derived entirely from existing in-repo topics.

FDA ADE report topic

  • ade_pentosan_adverse_events — FDA ADE reports for Pentosan Polysulfate Sodium (active ingredient) — total reports, species & reaction breakdown

Evidence topics referencing "pentosan"

  • evidence_joint_oa — Evidence cluster — osteoarthritis / joint supplements in dogs (peer-reviewed, Europe PMC)

Honest scope note

This is a term-co-occurrence cross-reference: the evidence topics above contain the term "pentosan" in their text, and the ADE topic aggregates FDA adverse-event reports for that active ingredient. Co-occurrence is not a clinical assertion that the literature studies the drug's adverse events. Verify against the linked source topics before drawing conclusions.

Sources

Cross-reference: \"pentosan\" — FDA ADE reports ↔ evidence literature
Source document: In-repo evidence (Europe PMC) + ADE (openFDA) topics
Derived cross-reference (existing in-repo topics)web/topics/ade/ade_pentosan_adverse_events/01_ade_pentosan_adverse_events.md, web/topics/evidence/evidence_joint_oa/01_evidence_joint_oa.mdretrieved 2026-08-11

Verification file: web/topics/ade/ade_pentosan_adverse_events/01_ade_pentosan_adverse_events.md, web/topics/evidence/evidence_joint_oa/01_evidence_joint_oa.md